Elanco Animal Health (ELAN) Retained Earnings (2017 - 2026)
Elanco Animal Health (ELAN) reported Retained Earnings of -$2.1 billion for Q1 2026, down 264.49% on a YoY basis from $1.3 billion in Q1 2025, and up 2.61% sequentially from -$2.2 billion in Q4 2025.
Elanco Animal Health (ELAN) Retained Earnings (2017 - 2026) Analysis & Trends
Elanco Animal Health (ELAN) has 10 years of Retained Earnings data on file, last reported at -$2.1 billion in Q1 2026.
- For the quarter ending Q1 2026, Retained Earnings fell 264.49% year-over-year to -$2.1 billion; the trailing twelve-month figure through Mar 2026 stood at -$2.1 billion (down 264.49% YoY), and the FY2025 full-year result was -$2.2 billion, down 124.75% from the prior year.
- Retained Earnings rose to -$2.1 billion in Q1 2026, from -$2.2 billion in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $8.9 billion in Q3 2025 to a low of -$2.2 billion in Q4 2025.
- A 5-year average of $1.3 billion and a median of -$392.0 million in 2022 frame the typical range for Retained Earnings.
- Across the five-year window, Retained Earnings sank 1520.0% in 2022 and soared 2931.29% in 2024, its largest moves.
- Tracing ELAN's Retained Earnings over 5 years: stood at -$392.0 million in 2022, then soared by 2339.03% to $8.8 billion in 2023, then rose by 0.46% to $8.8 billion in 2024, then sank by 124.75% to -$2.2 billion in 2025, then rose by 2.61% to -$2.1 billion in 2026.
- Business Quant data shows ELAN's Retained Earnings at -$2.1 billion in Q1 2026, -$2.2 billion in Q4 2025, and $8.9 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | 37.04 Bn |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | 28.20 Bn |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | 1.11 Bn |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | 4.54 Bn |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | 8.83 Bn |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | -413.76 Mn |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | 18.66 Bn |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | 589.60 Mn |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | -2.13 Bn |
| 10 | Vireo Growth | 10.53 Bn | 10.38 Bn | 59.30 Mn | -319.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.13 Bn |
| Dec 31, 2025 | -2.18 Bn |
| Sep 30, 2025 | 8.85 Bn |
| Jun 30, 2025 | -192.00 Mn |
| Mar 31, 2025 | -583.00 Mn |
| Dec 31, 2024 | 8.82 Bn |
| Sep 30, 2024 | -1.94 Bn |
| Jun 30, 2024 | -542.00 Mn |
| Mar 31, 2024 | 8.78 Bn |
| Dec 31, 2023 | 8.78 Bn |
| Sep 30, 2023 | -2.15 Bn |
| Jun 30, 2023 | -281.00 Mn |
| Mar 31, 2023 | -310.00 Mn |
| Dec 31, 2022 | -392.00 Mn |
| Sep 30, 2022 | -1.01 Bn |
| Jun 30, 2022 | -923.00 Mn |
| Mar 31, 2022 | -186.00 Mn |
| Dec 31, 2021 | -209.00 Mn |
| Sep 30, 2021 | 8.68 Bn |
| Jun 30, 2021 | 65.00 Mn |